BIT
ALBO

BlackRock Institutional Trust’s Albireo Pharma Inc ALBO Stock Holding History

BlackRock Institutional Trust’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$15K Sell
863
-1
-0.1% -$21 ﹤0.01% 3778
2016
Q3 		$11K Hold
864
– – ﹤0.01% 3838
2016
Q2 		$8K Hold
864
– – ﹤0.01% 3856
2016
Q1 		$9K Hold
864
– – ﹤0.01% 3899
2015
Q4 		$9K Hold
864
– – ﹤0.01% 3916
2015
Q3 		$11K Buy
864
+531
+159% +$13.4K ﹤0.01% 3915
2015
Q2 		$10K Buy
+333
New +$11.2K ﹤0.01% 3881

Other funds holding ALBO

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Institutional Trust's ALBO Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Albireo Pharma Inc (ALBO) stake by 0.12% in Q4 2016, selling an estimated $21 and leaving 863 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #3778.

BlackRock Institutional Trust first reported a position in ALBO in Q2 2015 and has held it in 7 quarters since. 19 funds tracked by Wall St. Rank hold ALBO as of Q4 2016.

  • BlackRock Institutional Trust held 863 shares of Albireo Pharma Inc worth $15K as of Q4 2016.
  • BlackRock Institutional Trust sold 1 Albireo Pharma Inc share in Q4 2016, an estimated $21.
  • Albireo Pharma Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3778 holding.
  • BlackRock Institutional Trust first reported a position in Albireo Pharma Inc in Q2 2015 and has held it in 7 quarters since.
  • 19 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.